BANK OF MONTREAL /CAN/ - NEOS THERAPEUTICS INC ownership

NEOS THERAPEUTICS INC's ticker is NEOS and the CUSIP is 64052L106. A total of 52 filers reported holding NEOS THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of NEOS THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$0115
+1816.7%
0.00%
Q1 2019$0
-100.0%
6
-99.1%
0.00%
Q4 2018$1,000
-75.0%
661
-33.6%
0.00%
Q3 2018$4,000
-33.3%
996
-0.5%
0.00%
Q2 2018$6,000
+50.0%
1,001
+100.2%
0.00%
Q1 2018$4,000500
+6150.0%
0.00%
Q3 2017$08
+300.0%
0.00%
Q2 2017$0
-100.0%
2
-100.0%
0.00%
Q1 2017$58,0008,000
+33233.3%
0.00%
Q4 2016$024
-47.8%
0.00%
Q3 2016$046
+130.0%
0.00%
Q2 2016$020
+185.7%
0.00%
Q1 2016$0
-100.0%
7
-75.0%
0.00%
Q3 2015$1,000280.00%
Other shareholders
NEOS THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 4,971,014$6,413,0004.42%
SPHERA FUNDS MANAGEMENT LTD. 3,711,454$4,788,0000.66%
Proxima Capital Management, LLC 206,000$266,0000.36%
Nantahala Capital Management 4,610,000$5,947,0000.18%
Alambic Investment Management, L.P. 219,090$283,0000.18%
Wealthstar Advisors, LLC 73,295$95,0000.06%
ALGERT GLOBAL LLC 77,845$100,0000.04%
Western Standard LLC 25,935$33,0000.02%
Allred Capital Management, LLC 24,995$33,0000.02%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 320,993$414,0000.02%
View complete list of NEOS THERAPEUTICS INC shareholders